SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Chemotherapy Plus Synthetic Compound Provides Potent Anti-Tumor Effect In Pancreatic Cancers, UT Southwestern Medical Center Research Shows
March 24, 2010
 · 
1 min read
Lone Star Bio
Leptin Therapy Shows Promise For Diabetes, UT Southwestern Medical Center Study
March 24, 2010
 · 
1 min read
Lone Star Bio
Following Protocols Can Reduce Medication Errors For Heart, Stroke Patients, Study in Circulation: Journal of the American Heart Association
March 23, 2010
 · 
3 min read
Lone Star Bio
New Bone-Hard Biomaterial for Surgical Screws, Fraunhofer Institute for Biomedical Technology Engineering IBMT Study
March 23, 2010
 · 
1 min read
Lone Star Bio
Blacks Less Likely Than Whites, Hispanics To Get Evidence-Based Stroke Care, Study in Circulation: Journal of the American Heart Association
March 23, 2010
 · 
4 min read
Lone Star Bio
New Chemotherapy Combination Shows Promise in Endometrial Cancer, University of Texas MD Anderson Cancer Center Researchers Find
March 19, 2010
 · 
1 min read
Lone Star Bio
New Attack On Cancer Forces Cells To Grow Old And Die, University of Texas MD Anderson Cancer Center Study
March 18, 2010
 · 
1 min read
Lone Star Bio
Hint of Chemoprevention Potential for Lynch Syndrome, M. D. Anderson Cancer Center Study
March 17, 2010
 · 
1 min read
Lone Star Bio
Spinal Restoration, Inc. Initiates Patient Enrollment for Phase III Study of Company’s Biostat(R) System
March 16, 2010
 · 
1 min read
Lone Star Bio
Disease Cause Is Pinpointed With Genome, Baylor College of Medicine Study
March 11, 2010
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Data Presented at SABCS 2025 Demonstrated that the Endocrine Activity Index® (EAI®) May Identify Patients Most Likely to Benefit from Extended Endocrine Therapy
February 16, 2026
 · 
3 min read
Press Releases
Moleculin Launches CEO Corner Platform to Share Strategic Insights
February 13, 2026
 · 
4 min read
Press Releases
Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update
February 13, 2026
 · 
11 min read
Press Releases
Medicenna Announces Changes to Board Composition
February 13, 2026
 · 
6 min read
Press Releases
Digital Disruption in Life Sciences: L7 Informatics Says Competitive Advantage Will Come From Governed Execution
February 12, 2026
 · 
1 min read
Press Releases
Tvardi Therapeutics to Participate in Upcoming Investor Conferences - February 12, 2026
February 12, 2026
 · 
1 min read
Press Releases
ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301
February 12, 2026
 · 
5 min read
Press Releases
Decoy Therapeutics Joins Webull Corporate Connect Service Platform
February 11, 2026
 · 
4 min read
Press Releases
IntraBio Reports Further Detail on Positive Data from Levacetylleucine Pivotal Trial for the Treatment of Ataxia-Telangiectasia
February 11, 2026
 · 
4 min read
Press Releases
Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026
February 11, 2026
 · 
5 min read
Load More